Molecular imaging in the development of a novel treatment paradigm for glioblastoma (GBM): an integrated multidisciplinary commentary.

Details

Serval ID
serval:BIB_E6D7F0409AFD
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Molecular imaging in the development of a novel treatment paradigm for glioblastoma (GBM): an integrated multidisciplinary commentary.
Journal
Drug Discovery Today
Author(s)
Jarzabek M.A., Sweeney K.J., Evans R.L., Jacobs A.H., Stupp R., O'Brien D., Berger M.S., Prehn J.H., Byrne A.T.
ISSN
1878-5832 (Electronic)
ISSN-L
1359-6446
Publication state
Published
Issued date
2013
Volume
18
Number
21-22
Pages
1052-1066
Language
english
Notes
Publication types: Journal ArticlePublication Status: ppublishDocument Type: Review
Abstract
Current therapeutic strategies against glioblastoma (GBM) have failed to prevent disease progression and recurrence effectively. The part played by molecular imaging (MI) in the development of novel therapies has gained increasing traction in recent years. For the first time, using expertise from an integrated multidisciplinary group of authors, herein we present a comprehensive evaluation of state-of-the-art GBM imaging and explore how advances facilitate the emergence of new treatment options. We propose a novel next-generation treatment paradigm based on the targeting of multiple hallmarks of cancer evolution that will heavily rely on MI.
Pubmed
Web of science
Create date
15/12/2013 15:53
Last modification date
20/08/2019 16:09
Usage data